A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

Clinical trial NCT02163993 · COMPLETED

Trial details

NCT number: NCT02163993
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Migraine Headache

Start date: 2014-07-07
Primary completion: 2015-08-19
Enrollment: 414

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.